• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌护理中的外科肿瘤学家和护士已准备好提供术前遗传咨询。

Surgical Oncologists and Nurses in Breast Cancer Care are Ready to Provide Pre-Test Genetic Counseling.

机构信息

Division Laboratories, Pharmacy and Biomedical Genetics, Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.

Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

出版信息

Ann Surg Oncol. 2023 Jun;30(6):3248-3258. doi: 10.1245/s10434-023-13229-5. Epub 2023 Feb 28.

DOI:10.1245/s10434-023-13229-5
PMID:36853565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10175452/
Abstract

BACKGROUND

Pre-test genetic counseling for patients with breast cancer is increasingly being provided by nongenetic healthcare professionals. We evaluated the attitudes, knowledge, and self-efficacy of surgeons, oncologists, and nurses regarding mainstream genetic testing and the feasibility to incorporate pre-test genetic counseling into routine care.

METHODS

We offered an online training to healthcare professionals from 13 hospitals and implemented a mainstream genetic testing pathway in 11/13 (85%) hospitals. Questionnaires were sent before (T0) and 6 months after (T1) completing the training. Those who did not complete the training received a questionnaire to assess their motivations.

RESULTS

In 11 hospitals, 80 (65%) healthcare professionals completed the training, of whom 70 (88%) completed both questionnaires. The attitudes, (perceived) knowledge and self-efficacy of healthcare professionals were high both at baseline and 6 months after completing the training. After 6 months, their perceived knowledge about the advantages and disadvantages of a genetic test and implications for family members had significantly improved (p = 0.012 and p = 0.021, respectively). For the majority (89%), the time investment for pre-test genetic counseling was less than 15 min per patient and as expected or better. Healthcare professionals considered the total time investment feasible to incorporate mainstream genetic testing into their daily practice. The main barrier to complete the training was lack of time. The online training was considered useful, with a rating of 8/10.

CONCLUSION

Surgical oncologists and nurses in breast cancer care feel well-equipped and motivated to provide pre-test genetic counseling after completion of an online training module.

摘要

背景

越来越多的非遗传健康专业人员为乳腺癌患者提供预测试遗传咨询。我们评估了外科医生、肿瘤医生和护士对主流基因检测的态度、知识和自我效能感,以及将预测试遗传咨询纳入常规护理的可行性。

方法

我们为 13 家医院的医疗保健专业人员提供了在线培训,并在 11/13(85%)家医院实施了主流基因检测途径。在完成培训前后(T0 和 T1)发送了问卷。那些没有完成培训的人收到了一份问卷,以评估他们的动机。

结果

在 11 家医院中,有 80 名(65%)医疗保健专业人员完成了培训,其中 70 名(88%)完成了两份问卷。医护人员的态度、(感知)知识和自我效能感在基线和完成培训后 6 个月都很高。6 个月后,他们对基因检测的优缺点和对家庭成员的影响的感知知识显著提高(p=0.012 和 p=0.021)。对于大多数人(89%)来说,每个患者的预测试遗传咨询时间投入少于 15 分钟,并且与预期或更好。医疗保健专业人员认为,将主流基因检测纳入日常实践的总时间投入是可行的。完成培训的主要障碍是缺乏时间。在线培训被认为是有用的,评分为 8/10。

结论

完成在线培训模块后,乳腺癌护理中的外科肿瘤医生和护士感到有能力并愿意提供预测试遗传咨询。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b631/10175452/f56409d0601c/10434_2023_13229_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b631/10175452/3ac3731c55b6/10434_2023_13229_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b631/10175452/bd5f47bccf75/10434_2023_13229_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b631/10175452/f56409d0601c/10434_2023_13229_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b631/10175452/3ac3731c55b6/10434_2023_13229_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b631/10175452/bd5f47bccf75/10434_2023_13229_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b631/10175452/f56409d0601c/10434_2023_13229_Fig3_HTML.jpg

相似文献

1
Surgical Oncologists and Nurses in Breast Cancer Care are Ready to Provide Pre-Test Genetic Counseling.乳腺癌护理中的外科肿瘤学家和护士已准备好提供术前遗传咨询。
Ann Surg Oncol. 2023 Jun;30(6):3248-3258. doi: 10.1245/s10434-023-13229-5. Epub 2023 Feb 28.
2
Positive experiences of healthcare professionals with a mainstreaming approach of germline genetic testing for women with ovarian cancer.医护人员对卵巢癌女性进行种系基因检测主流化方法的积极体验。
Fam Cancer. 2022 Jul;21(3):295-304. doi: 10.1007/s10689-021-00277-7. Epub 2021 Oct 7.
3
Patients' experiences with pre-test genetic counseling provided by breast cancer healthcare professionals: Results from a large prospective multicenter study.患者对乳腺癌医护人员提供的预测试遗传咨询的体验:一项大型前瞻性多中心研究的结果。
Breast. 2023 Jun;69:349-357. doi: 10.1016/j.breast.2023.03.017. Epub 2023 Mar 29.
4
Systematic development of a training program for healthcare professionals to improve communication about breast cancer genetic counseling with low health literate patients.为医疗保健专业人员制定培训计划,以改善与低健康素养患者的乳腺癌遗传咨询沟通。
Fam Cancer. 2020 Oct;19(4):281-290. doi: 10.1007/s10689-020-00176-3.
5
Attitudes and training needs of oncologists and surgeons in mainstreaming breast cancer genetic counseling in a low-to-middle income Asian country.在一个中低收入的亚洲国家,将乳腺癌遗传咨询纳入主流,肿瘤学家和外科医生的态度和培训需求。
J Genet Couns. 2022 Oct;31(5):1080-1089. doi: 10.1002/jgc4.1579. Epub 2022 Apr 28.
6
Effect of a health literacy training program for surgical oncologists and specialized nurses on disparities in referral to breast cancer genetic testing.外科肿瘤学家和专科护士健康素养培训计划对乳腺癌遗传检测转诊差异的影响。
Breast. 2021 Aug;58:80-87. doi: 10.1016/j.breast.2021.04.008. Epub 2021 Apr 22.
7
Roll-out of an educational workshop to improve knowledge and self-confidence of healthcare professionals engaged in mainstreaming of breast cancer genetics.开展教育研讨会,提高从事乳腺癌遗传学主流化工作的医疗保健专业人员的知识和自信。
PLoS One. 2024 Jul 19;19(7):e0307301. doi: 10.1371/journal.pone.0307301. eCollection 2024.
8
Mainstream germline genetic testing in men with metastatic prostate cancer: design and protocol for a multicenter observational study.转移性前列腺癌男性的主流种系基因检测:一项多中心观察性研究的设计和方案。
BMC Cancer. 2022 Dec 30;22(1):1365. doi: 10.1186/s12885-022-10429-2.
9
Physicians' experience, practice and education, on genetic testing and genetic counseling: a nationwide survey study in Greece.医生在基因检测和遗传咨询方面的经验、实践和教育:希腊全国调查研究。
Fam Cancer. 2022 Oct;21(4):479-487. doi: 10.1007/s10689-022-00290-4. Epub 2022 Jan 24.
10
Communication about breast cancer genetic counseling with patients with limited health literacy or a migrant background: evaluation of a training program for healthcare professionals.针对健康素养有限或有移民背景的患者进行乳腺癌遗传咨询的沟通:对医疗保健专业人员培训项目的评估
J Community Genet. 2021 Jan;12(1):91-99. doi: 10.1007/s12687-020-00497-x. Epub 2020 Dec 15.

引用本文的文献

1
Knowledge and Attitudes of Nurses Toward Genetics and Genomics: A Scoping Review.护士对遗传学和基因组学的知识与态度:一项范围综述
Cureus. 2025 Aug 28;17(8):e91196. doi: 10.7759/cureus.91196. eCollection 2025 Aug.
2
The impact of a mainstream genetic testing pathway and socioeconomic factors on the uptake of germline genetic testing in breast cancer patients: results of the nationwide GENE-SMART study.主流基因检测途径和社会经济因素对乳腺癌患者接受种系基因检测的影响:全国性GENE-SMART研究结果
Breast Cancer Res. 2025 Jul 14;27(1):129. doi: 10.1186/s13058-025-02081-y.
3
Experience of urologists, oncologists and nurse practitioners with mainstream genetic testing in metastatic prostate cancer.

本文引用的文献

1
Attitudes and training needs of oncologists and surgeons in mainstreaming breast cancer genetic counseling in a low-to-middle income Asian country.在一个中低收入的亚洲国家,将乳腺癌遗传咨询纳入主流,肿瘤学家和外科医生的态度和培训需求。
J Genet Couns. 2022 Oct;31(5):1080-1089. doi: 10.1002/jgc4.1579. Epub 2022 Apr 28.
2
The Feasibility of Implementing Mainstream Germline Genetic Testing in Routine Cancer Care-A Systematic Review.在常规癌症护理中实施主流种系基因检测的可行性——一项系统评价
Cancers (Basel). 2022 Feb 19;14(4):1059. doi: 10.3390/cancers14041059.
3
Breast and Ovarian Cancer Penetrance Estimates Derived From Germline Multiple-Gene Sequencing Results in Women.
泌尿外科医生、肿瘤学家和执业护士在转移性前列腺癌主流基因检测方面的经验。
Prostate Cancer Prostatic Dis. 2024 Dec 5. doi: 10.1038/s41391-024-00925-w.
4
Mainstream Germline Genetic Testing with Expanded Eligibility for Early Breast Cancer Patients in a Large Integrated Health System.大型综合医疗系统中对早期乳腺癌患者扩大适用范围的主流种系基因检测。
Ann Surg Oncol. 2025 Jan;32(1):75-83. doi: 10.1245/s10434-024-16223-7. Epub 2024 Sep 18.
5
Ensuring best practice in genomics education: A scoping review of genomics education needs assessments and evaluations.确保基因组学教育的最佳实践:对基因组学教育需求评估和评价的范围综述。
Am J Hum Genet. 2024 Aug 8;111(8):1508-1523. doi: 10.1016/j.ajhg.2024.06.005. Epub 2024 Jul 2.
基于女性种系多基因测序结果得出的乳腺癌和卵巢癌外显率估计值。
JCO Precis Oncol. 2017 Nov;1:1-12. doi: 10.1200/PO.16.00066.
4
"It was an important part of my treatment": a qualitative study of Norwegian breast Cancer patients' experiences with mainstreamed genetic testing.“这是我治疗过程中的重要组成部分”:一项关于挪威乳腺癌患者主流基因检测体验的定性研究
Hered Cancer Clin Pract. 2022 Feb 5;20(1):6. doi: 10.1186/s13053-022-00212-6.
5
Positive experiences of healthcare professionals with a mainstreaming approach of germline genetic testing for women with ovarian cancer.医护人员对卵巢癌女性进行种系基因检测主流化方法的积极体验。
Fam Cancer. 2022 Jul;21(3):295-304. doi: 10.1007/s10689-021-00277-7. Epub 2021 Oct 7.
6
Adjuvant Olaparib for Patients with - or -Mutated Breast Cancer.奥拉帕利辅助治疗 - 或 - 突变型乳腺癌患者。
N Engl J Med. 2021 Jun 24;384(25):2394-2405. doi: 10.1056/NEJMoa2105215. Epub 2021 Jun 3.
7
Pilot study of an online training program to increase genetic literacy and communication skills in oncology healthcare professionals discussing BRCA1/2 genetic testing with breast and ovarian cancer patients.一项在线培训计划的初步研究,旨在提高肿瘤医疗保健专业人员在与乳腺癌和卵巢癌患者讨论 BRCA1/2 基因检测时的基因知识和沟通技巧。
Fam Cancer. 2022 Apr;21(2):157-166. doi: 10.1007/s10689-021-00261-1. Epub 2021 May 10.
8
A Comparison of Patient-Reported Outcomes Following Consent for Genetic Testing Using an Oncologist- or Genetic Counselor-Mediated Model of Care.基于肿瘤医生或遗传咨询师介导的护理模式,比较患者在同意进行基因检测后的报告结局。
Curr Oncol. 2021 Apr 8;28(2):1459-1471. doi: 10.3390/curroncol28020138.
9
Mainstream genetic testing for breast cancer patients: early experiences from the Parkville Familial Cancer Centre.主流的乳腺癌患者基因检测:来自帕克维尔家族癌症中心的早期经验。
Eur J Hum Genet. 2021 May;29(5):872-880. doi: 10.1038/s41431-021-00848-3. Epub 2021 Mar 15.
10
An Overview of PARP Inhibitors for the Treatment of Breast Cancer.PARP 抑制剂在乳腺癌治疗中的概述。
Target Oncol. 2021 May;16(3):255-282. doi: 10.1007/s11523-021-00796-4. Epub 2021 Mar 12.